Myovant Sciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYOVANT SCIENCES, and when can generic versions of MYOVANT SCIENCES drugs launch?
MYOVANT SCIENCES has one approved drug.
There are six US patents protecting MYOVANT SCIENCES drugs.
There are one hundred and fifteen patent family members on MYOVANT SCIENCES drugs in thirty-four countries and twenty-eight supplementary protection certificates in fifteen countries.
Summary for Myovant Sciences
International Patents: | 115 |
US Patents: | 6 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Myovant Sciences
Expired US Patents for Myovant Sciences
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Myovant Sciences | MYFEMBREE | estradiol; norethindrone acetate; relugolix | TABLET;ORAL | 214846-001 | May 26, 2021 | 9,346,822 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Myovant Sciences Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 2900675 | ⤷ Try a Trial |
Norway | 331981 | ⤷ Try a Trial |
Morocco | 46353 | ⤷ Try a Trial |
Argentina | 110636 | ⤷ Try a Trial |
Japan | 7043503 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Myovant Sciences Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1214076 | C01214076/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
1453521 | 122015000093 | Germany | ⤷ Try a Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
1591446 | 2022C/501 | Belgium | ⤷ Try a Trial | PRODUCT NAME: RELUGOLIX OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/21/1565 20210720 |
0398460 | 12/2004 | Austria | ⤷ Try a Trial | PRODUCT NAME: DROSPIRENON IN KOMBINATION MIT ESTRADIOL; NAT. REGISTRATION NO/DATE: 1-25178, 1-25179 20031127; FIRST REGISTRATION: NL RVG 27505 20021211 |
1591446 | 122022000002 | Germany | ⤷ Try a Trial | PRODUCT NAME: RELUGOLIX ODER EIN SALZ DAVON; REGISTRATION NO/DATE: EU/1/21/1565 20210716 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.